Catalyst Pharmaceuticals (CPRX) Return on Capital Employed Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -893.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -893.00 |
| Dec 31, 2025 | -661.00 |
| Sep 30, 2025 | -348.00 |
| Jun 30, 2025 | -155.00 |
| Mar 31, 2025 | 279.00 |
| Dec 31, 2024 | 249.00 |
| Sep 30, 2024 | 277.00 |
| Jun 30, 2024 | -987.00 |
| Mar 31, 2024 | -605.00 |
| Dec 31, 2023 | -193.00 |
| Sep 30, 2023 | -969.00 |
| Jun 30, 2023 | -397.00 |
| Mar 31, 2023 | -876.00 |
| Dec 31, 2022 | -525.00 |
| Sep 30, 2022 | 1,987.00 |
| Jun 30, 2022 | 5,449.00 |
| Mar 31, 2022 | 8,598.00 |
| Dec 31, 2021 | 9,043.00 |
| Sep 30, 2021 | 6,312.00 |
| Jun 30, 2021 | 5,457.00 |
| Mar 31, 2021 | 4,747.00 |
| Dec 31, 2020 | 5,919.00 |
| Sep 30, 2020 | 8,384.00 |
| Jun 30, 2020 | 8,984.00 |
| Mar 31, 2020 | 9,152.00 |
| Dec 31, 2019 | 8,612.00 |
| Sep 30, 2019 | 5,980.00 |
| Jun 30, 2019 | 2,191.00 |
| Mar 31, 2019 | -1,745.00 |
| Dec 31, 2018 | -3,004.00 |
| Sep 30, 2018 | -1,005.00 |
| Jun 30, 2018 | -518.00 |
| Mar 31, 2018 | 334.00 |
| Dec 31, 2017 | 388.00 |
| Sep 30, 2017 | -2,035.00 |
| Jun 30, 2017 | -957.00 |
| Mar 31, 2017 | 982.00 |
| Dec 31, 2016 | -513.00 |
| Sep 30, 2016 | 486.00 |
| Mar 31, 2015 | 9,666.00 |
| Dec 31, 2014 | 9,960.00 |
| Sep 30, 2014 | 7,216.00 |